All
Targeted Therapy for Certain Leukemias Continues to Impress in Phase 2 Trial
Ponatinib continues to make improvements in phase 2 CML study.
Velcade-based Therapy Shows Benefit in Multiple Myeloma
Velcade-based therapy shows benefit in multiple myeloma trial called GIMEMA.
Moving Away from Chemo in Acute Promyelocytic Leukemia
A study shows that a chemotherapy-free regimen may be better in acute promyelocytic leukemia.
Targeted therapy for certain leukemias receives FDA approval ahead of schedule
Medicare Resources
Find information and resources on Medicare.
Learning about CML
One year of Herceptin optimal for HER2-positive breast cancer
When people want to help, say yes
Moving away from chemo in acute promyelocytic leukemia
Do you watch and wait?
A recap of triple-negative breast cancer research from San Antonio
How do we treat local recurrence of breast cancer?
Where are the survivorship studies?
Advocates fighting for the lives of those with metastatic disease
Study confirms higher dose of Faslodex needed
Should women take 10 years of tamoxifen to prevent breast cancer recurrence?
A city filled with passion
Hobnobbing with the docs
Giving African-American women a voice
Breast cancer advocates a visible presence in San Antonio
Happy Thanksgiving 2012
Supporting the man with prostate cancer: The ground rules
BreastCancerTrials.org gets an update
A month of memories during October
Pay it forward
Gains in lung cancer
The challenges of a gastrectomy and how it helped me win my battle with stomach cancer
The Great American Smokeout: Nov. 15
2006 – 20 years
Movember is here: Letting it grow for a cancer cause